The efficacy of palonosetron for the prevention of postoperative nausea and vomiting : a randomized double-blinded, placebo-controlled trial.

Trial Profile

The efficacy of palonosetron for the prevention of postoperative nausea and vomiting : a randomized double-blinded, placebo-controlled trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Palonosetron (Primary)
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Oct 2013 Primary endpoint has been met as result published in the British Journal of Anaesthesia.
    • 27 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top